|
Mingpan Cheng obtained his Ph.D. in 2018 from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, and subsequently conducted postdoctoral researches in France and Germany. In 2022, he joined the Department of Biomedical Engineering in China Pharmaceutical University as full Professor, established a nucleic acid research laboratory. He was supported by the National High-level Young Talents Program (2023), Jiangsu Specially-Appointed Professor (2022). He has been engaged in research in nucleic acid chemical biology, nucleic acid drugs, molecular diagnostics and DNA catalysis.
1. ACS Catal., 2023, 13, 10722-10733. 2. J. Am. Chem. Soc., 2021, 143, 7792-7807. 3. Angew. Chem., Int. Ed., 2021, 60, 10286-10294. 4. Angew. Chem., Int. Ed., 2021, 60, 10295-10303. 5. Nucleic Acids Res., 2021, 49, 9548-9559. 6. Nucleic Acids Res., 2018, 46, 9264-9275. |


